Skip to main content
Premium Trial:

Request an Annual Quote

Startup Biomarker Instrument Firm Avantra Biosciences Raises $7M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Newly formed Avantra Biosciences has raised $7 million, it disclosed in a document filed with the US Securities and Exchange Commission on Monday.

The Woburn, Mass.-based firm said the funds raised were in the form of equity and will not be used for a merger, acquisition, exchange offer, or other business combination transaction. It did not specify how the money will be used, but last month GenomeWeb Daily News' sister publication ProteoMonitor reported that Avantra plans to launch the Avantra Biomarker Workstation and accompanying assays early next year after closing of the Series B round.

Avantra was launched at the end of last year by Courtagen Capital Group from the ashes of Decision Biomarkers. Courtagen bought the assets of Decision Biomarkers after the protein biomarker technology firm shuttered its business and filed for Chapter 7 bankruptcy.

The Biomarker Workstation was developed by Decision Biomarkers and is used for biomarker detection.

In its SEC filing, Avantra lists Brian McKernan as its CEO and Brendan McKernan as its president.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.